RUSSELL BALMER: Open Payments
NPI 1861699100 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,352 in 22 payments from 6 companies in 2025. Trend: 2023 $44 · 2024 $55 · 2025 $1,352
Food & beverage: $1,352
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $707 |
| Teva Pharmaceuticals USA, Inc. | 7 | $353 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Alkermes, Inc. | 1 | $81 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
Products named: COBENFY, UZEDY, CAPLYTA, ARISTADA, INVEGA SUSTENNA, INGREZZA.
Industry payments across VA — which companies pay providers there.
